Annual EBITDA
$138.98 M
-$92.87 M-40.05%
31 December 2023
Summary:
Nu Skin Enterprises annual earnings before interest, taxes, depreciation & amortization is currently $138.98 million, with the most recent change of -$92.87 million (-40.05%) on 31 December 2023. During the last 3 years, it has fallen by -$192.57 million (-58.08%). NUS annual EBITDA is now -76.41% below its all-time high of $589.03 million, reached on 31 December 2013.NUS EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
$37.12 M
+$144.44 M+134.59%
30 September 2024
Summary:
Nu Skin Enterprises quarterly earnings before interest, taxes, depreciation & amortization is currently $37.12 million, with the most recent change of +$144.44 million (+134.59%) on 30 September 2024. Over the past year, it has increased by +$45.84 million (+525.48%). NUS quarterly EBITDA is now -81.39% below its all-time high of $199.49 million, reached on 31 December 2013.NUS Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
$7.86 M
+$45.84 M+120.68%
30 September 2024
Summary:
Nu Skin Enterprises TTM earnings before interest, taxes, depreciation & amortization is currently $7.86 million, with the most recent change of +$45.84 million (+120.68%) on 30 September 2024. Over the past year, it has dropped by -$144.32 million (-94.84%). NUS TTM EBITDA is now -98.72% below its all-time high of $612.21 million, reached on 31 March 2014.NUS TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NUS EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -40.0% | +525.5% | -94.8% |
| 3 y3 years | -58.1% | -56.5% | -97.9% |
| 5 y5 years | -64.8% | -58.4% | -97.9% |
NUS EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -61.6% | at low | -59.0% | +134.6% | -97.9% | +120.7% |
| 5 y | 5 years | -64.8% | at low | -65.4% | +134.6% | -98.0% | +120.7% |
| alltime | all time | -76.4% | +128.6% | -81.4% | +111.1% | -98.7% | +104.5% |
Nu Skin Enterprises EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $37.12 M(-134.6%) | $7.86 M(-120.7%) |
| June 2024 | - | -$107.33 M(-499.5%) | -$37.99 M(-129.4%) |
| Mar 2024 | - | $26.86 M(-47.5%) | $129.38 M(-6.9%) |
| Dec 2023 | $138.98 M(-40.1%) | $51.20 M(-686.9%) | $138.98 M(-8.7%) |
| Sept 2023 | - | -$8.72 M(-114.5%) | $152.18 M(-19.4%) |
| June 2023 | - | $60.05 M(+64.7%) | $188.92 M(-5.1%) |
| Mar 2023 | - | $36.46 M(-43.4%) | $199.03 M(-14.2%) |
| Dec 2022 | $231.85 M(-36.0%) | $64.40 M(+129.9%) | $231.85 M(-10.2%) |
| Sept 2022 | - | $28.01 M(-60.1%) | $258.10 M(-18.2%) |
| June 2022 | - | $70.16 M(+1.3%) | $315.40 M(-9.9%) |
| Mar 2022 | - | $69.28 M(-23.6%) | $350.20 M(-3.3%) |
| Dec 2021 | $362.18 M(+9.2%) | $90.65 M(+6.3%) | $362.18 M(-4.4%) |
| Sept 2021 | - | $85.32 M(-18.7%) | $378.94 M(-1.8%) |
| June 2021 | - | $104.96 M(+29.2%) | $385.77 M(+8.0%) |
| Mar 2021 | - | $81.26 M(-24.3%) | $357.15 M(+7.7%) |
| Dec 2020 | $331.56 M(-3.6%) | $107.41 M(+16.6%) | $331.56 M(+11.4%) |
| Sept 2020 | - | $92.15 M(+20.7%) | $297.51 M(+1.0%) |
| June 2020 | - | $76.34 M(+37.2%) | $294.56 M(-5.4%) |
| Mar 2020 | - | $55.66 M(-24.1%) | $311.48 M(-9.5%) |
| Dec 2019 | $344.08 M(-12.8%) | $73.36 M(-17.7%) | $344.08 M(-9.5%) |
| Sept 2019 | - | $89.20 M(-4.4%) | $380.00 M(-3.6%) |
| June 2019 | - | $93.25 M(+5.7%) | $394.17 M(-2.7%) |
| Mar 2019 | - | $88.26 M(-19.2%) | $404.91 M(+2.6%) |
| Dec 2018 | $394.55 M(+14.0%) | $109.29 M(+5.7%) | $394.55 M(-2.2%) |
| Sept 2018 | - | $103.37 M(-0.6%) | $403.42 M(+5.6%) |
| June 2018 | - | $104.00 M(+33.5%) | $381.86 M(+6.1%) |
| Mar 2018 | - | $77.90 M(-34.1%) | $360.06 M(+4.0%) |
| Dec 2017 | $346.05 M(+14.0%) | $118.16 M(+44.4%) | $346.05 M(+12.5%) |
| Sept 2017 | - | $81.81 M(-0.5%) | $307.67 M(-5.9%) |
| June 2017 | - | $82.19 M(+28.7%) | $326.95 M(-4.5%) |
| Mar 2017 | - | $63.89 M(-19.9%) | $342.29 M(+12.8%) |
| Dec 2016 | $303.50 M(-4.0%) | $79.78 M(-21.1%) | $303.50 M(-0.4%) |
| Sept 2016 | - | $101.09 M(+3.6%) | $304.70 M(+15.4%) |
| June 2016 | - | $97.54 M(+288.7%) | $264.15 M(+3.2%) |
| Mar 2016 | - | $25.09 M(-69.0%) | $255.92 M(-19.0%) |
| Dec 2015 | $316.07 M(-22.4%) | $80.98 M(+33.8%) | $316.07 M(-7.7%) |
| Sept 2015 | - | $60.54 M(-32.2%) | $342.38 M(-14.6%) |
| June 2015 | - | $89.31 M(+4.8%) | $400.76 M(+5.8%) |
| Mar 2015 | - | $85.24 M(-20.6%) | $378.90 M(-6.9%) |
| Dec 2014 | $407.11 M(-30.9%) | $107.29 M(-9.8%) | $407.11 M(-18.5%) |
| Sept 2014 | - | $118.92 M(+76.3%) | $499.31 M(-10.4%) |
| June 2014 | - | $67.45 M(-40.5%) | $557.16 M(-9.0%) |
| Mar 2014 | - | $113.45 M(-43.1%) | $612.21 M(+3.9%) |
| Dec 2013 | $589.03 M(+57.4%) | $199.49 M(+12.9%) | $589.03 M(+21.0%) |
| Sept 2013 | - | $176.77 M(+44.3%) | $486.63 M(+21.5%) |
| June 2013 | - | $122.50 M(+35.7%) | $400.51 M(+4.2%) |
| Mar 2013 | - | $90.27 M(-7.0%) | $384.36 M(+2.7%) |
| Dec 2012 | $374.26 M(+40.4%) | $97.09 M(+7.1%) | $374.26 M(+3.5%) |
| Sept 2012 | - | $90.66 M(-14.8%) | $361.57 M(+4.4%) |
| June 2012 | - | $106.35 M(+32.7%) | $346.30 M(+10.3%) |
| Mar 2012 | - | $80.17 M(-5.0%) | $313.93 M(+17.8%) |
| Dec 2011 | $266.59 M(+8.1%) | $84.41 M(+12.0%) | $266.59 M(+7.4%) |
| Sept 2011 | - | $75.38 M(+1.9%) | $248.12 M(+6.4%) |
| June 2011 | - | $73.98 M(+125.4%) | $233.20 M(+3.1%) |
| Mar 2011 | - | $32.83 M(-50.2%) | $226.10 M(-8.3%) |
| Dec 2010 | $246.68 M(+40.6%) | $65.93 M(+9.0%) | $246.68 M(+8.4%) |
| Sept 2010 | - | $60.46 M(-9.6%) | $227.57 M(+5.5%) |
| June 2010 | - | $66.88 M(+25.2%) | $215.74 M(+12.4%) |
| Mar 2010 | - | $53.41 M(+14.1%) | $191.94 M(+9.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2009 | $175.48 M(+27.2%) | $46.82 M(-3.7%) | $175.48 M(+11.7%) |
| Sept 2009 | - | $48.63 M(+12.9%) | $157.16 M(+7.4%) |
| June 2009 | - | $43.08 M(+16.6%) | $146.28 M(+4.9%) |
| Mar 2009 | - | $36.95 M(+29.6%) | $139.50 M(+1.1%) |
| Dec 2008 | $137.95 M(+25.7%) | $28.50 M(-24.5%) | $137.95 M(+0.4%) |
| Sept 2008 | - | $37.76 M(+4.0%) | $137.40 M(+8.3%) |
| June 2008 | - | $36.30 M(+2.6%) | $126.90 M(+6.0%) |
| Mar 2008 | - | $35.39 M(+26.6%) | $119.77 M(+9.1%) |
| Dec 2007 | $109.75 M(+15.6%) | $27.96 M(+2.6%) | $109.75 M(-4.7%) |
| Sept 2007 | - | $27.26 M(-6.5%) | $115.12 M(-0.5%) |
| June 2007 | - | $29.16 M(+15.0%) | $115.75 M(-1.1%) |
| Mar 2007 | - | $25.37 M(-23.9%) | $117.09 M(+23.3%) |
| Dec 2006 | $94.95 M(-38.5%) | $33.33 M(+19.5%) | $94.95 M(-1.9%) |
| Sept 2006 | - | $27.89 M(-8.5%) | $96.82 M(-9.5%) |
| June 2006 | - | $30.50 M(+844.1%) | $106.99 M(-11.9%) |
| Mar 2006 | - | $3.23 M(-90.8%) | $121.43 M(-21.4%) |
| Dec 2005 | $154.49 M(+0.0%) | $35.20 M(-7.5%) | $154.49 M(-3.6%) |
| Sept 2005 | - | $38.06 M(-15.3%) | $160.26 M(-1.5%) |
| June 2005 | - | $44.93 M(+23.8%) | $162.73 M(+1.3%) |
| Mar 2005 | - | $36.29 M(-11.4%) | $160.59 M(+4.0%) |
| Dec 2004 | $154.42 M(+13.6%) | $40.97 M(+1.1%) | $154.42 M(-1.6%) |
| Sept 2004 | - | $40.54 M(-5.3%) | $156.87 M(+3.1%) |
| June 2004 | - | $42.79 M(+42.0%) | $152.16 M(+8.1%) |
| Mar 2004 | - | $30.13 M(-30.6%) | $140.81 M(+3.5%) |
| Dec 2003 | $135.98 M(+6.7%) | $43.42 M(+21.2%) | $135.98 M(+7.2%) |
| Sept 2003 | - | $35.83 M(+14.0%) | $126.82 M(+3.5%) |
| June 2003 | - | $31.43 M(+24.2%) | $122.47 M(-3.6%) |
| Mar 2003 | - | $25.30 M(-26.1%) | $127.06 M(-0.3%) |
| Dec 2002 | $127.41 M(+22.6%) | $34.25 M(+8.8%) | $127.41 M(+6.3%) |
| Sept 2002 | - | $31.49 M(-12.6%) | $119.88 M(+3.2%) |
| June 2002 | - | $36.01 M(+40.4%) | $116.21 M(+7.5%) |
| Mar 2002 | - | $25.66 M(-4.0%) | $108.08 M(+4.0%) |
| Dec 2001 | $103.91 M(-18.8%) | $26.71 M(-4.0%) | $103.91 M(-2.8%) |
| Sept 2001 | - | $27.83 M(-0.2%) | $106.94 M(-4.6%) |
| June 2001 | - | $27.88 M(+29.7%) | $112.06 M(-5.6%) |
| Mar 2001 | - | $21.49 M(-27.8%) | $118.75 M(-7.2%) |
| Dec 2000 | $128.01 M(-21.4%) | $29.75 M(-9.7%) | $128.02 M(+1.0%) |
| Sept 2000 | - | $32.95 M(-4.7%) | $126.77 M(-5.0%) |
| June 2000 | - | $34.56 M(+12.4%) | $133.42 M(-3.8%) |
| Mar 2000 | - | $30.76 M(+7.9%) | $138.76 M(-14.9%) |
| Dec 1999 | $162.90 M(-22.7%) | $28.50 M(-28.0%) | $163.00 M(-15.9%) |
| Sept 1999 | - | $39.60 M(-0.8%) | $193.90 M(-5.1%) |
| June 1999 | - | $39.90 M(-27.5%) | $204.30 M(-3.1%) |
| Mar 1999 | - | $55.00 M(-7.4%) | $210.80 M(-0.0%) |
| Dec 1998 | $210.80 M(-0.7%) | $59.40 M(+18.8%) | $210.90 M(+0.4%) |
| Sept 1998 | - | $50.00 M(+7.8%) | $210.10 M(-1.5%) |
| June 1998 | - | $46.40 M(-15.8%) | $213.40 M(-5.1%) |
| Mar 1998 | - | $55.10 M(-6.0%) | $224.80 M(+3.7%) |
| Dec 1997 | $212.20 M(+42.2%) | $58.60 M(+9.9%) | $216.70 M(-223.1%) |
| Sept 1997 | - | $53.30 M(-7.8%) | -$176.10 M(+284.5%) |
| June 1997 | - | $57.80 M(+23.0%) | -$45.80 M(-176.5%) |
| Mar 1997 | - | $47.00 M(-114.1%) | $59.90 M(-56.3%) |
| Dec 1996 | $149.20 M(+145.4%) | -$334.20 M(-282.0%) | $137.10 M(-52.5%) |
| Sept 1996 | - | $183.60 M(+12.3%) | $288.70 M(+53.3%) |
| June 1996 | - | $163.50 M(+31.6%) | $188.30 M(+78.8%) |
| Mar 1996 | - | $124.20 M(-168.0%) | $105.30 M(+79.1%) |
| Dec 1995 | $60.80 M | -$182.60 M(-319.5%) | $58.80 M(-75.6%) |
| Sept 1995 | - | $83.20 M(+3.4%) | $241.40 M(+52.6%) |
| June 1995 | - | $80.50 M(+3.6%) | $158.20 M(+103.6%) |
| Mar 1995 | - | $77.70 M | $77.70 M |
FAQ
- What is Nu Skin Enterprises annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for Nu Skin Enterprises?
- What is Nu Skin Enterprises annual EBITDA year-on-year change?
- What is Nu Skin Enterprises quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for Nu Skin Enterprises?
- What is Nu Skin Enterprises quarterly EBITDA year-on-year change?
- What is Nu Skin Enterprises TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for Nu Skin Enterprises?
- What is Nu Skin Enterprises TTM EBITDA year-on-year change?
What is Nu Skin Enterprises annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of NUS is $138.98 M
What is the all time high annual EBITDA for Nu Skin Enterprises?
Nu Skin Enterprises all-time high annual earnings before interest, taxes, depreciation & amortization is $589.03 M
What is Nu Skin Enterprises annual EBITDA year-on-year change?
Over the past year, NUS annual earnings before interest, taxes, depreciation & amortization has changed by -$92.87 M (-40.05%)
What is Nu Skin Enterprises quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of NUS is $37.12 M
What is the all time high quarterly EBITDA for Nu Skin Enterprises?
Nu Skin Enterprises all-time high quarterly earnings before interest, taxes, depreciation & amortization is $199.49 M
What is Nu Skin Enterprises quarterly EBITDA year-on-year change?
Over the past year, NUS quarterly earnings before interest, taxes, depreciation & amortization has changed by +$45.84 M (+525.48%)
What is Nu Skin Enterprises TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of NUS is $7.86 M
What is the all time high TTM EBITDA for Nu Skin Enterprises?
Nu Skin Enterprises all-time high TTM earnings before interest, taxes, depreciation & amortization is $612.21 M
What is Nu Skin Enterprises TTM EBITDA year-on-year change?
Over the past year, NUS TTM earnings before interest, taxes, depreciation & amortization has changed by -$144.32 M (-94.84%)